The role of complement in biomaterial-induced inflammation
- PMID: 16905192
- DOI: 10.1016/j.molimm.2006.06.020
The role of complement in biomaterial-induced inflammation
Abstract
Biomaterials are regularly used in various types of artificial tissues and organs, such as oxygenators, plasmapheresis equipment, hemodialysers, catheters, prostheses, stents, vascular grafts, miniature pumps, sensors and heart aids. Although progress has been made regarding bioincompatibility, many materials and procedures are associated with side effects, in particular bioincompatibility-induced inflammation, infections and subsequent loss of function. After cardiopulmonary bypass, coagulopathies can occur and lead to cognitive disturbances, stroke and extended hospitalization. Hemodialysis is associated with anaphylatoid reactions that cause whole-body inflammation and may contribute to accelerated arteriosclerosis. Stents cause restenosis and, in severe cases, thrombotic reactions. This situation indicates that there is still a need to try to understand the mechanisms involved in these incompatibility reactions in order to be able to improve the biomaterials and to develop treatments that attenuate the reactions and thereby reduce patients' discomfort, treatment time and cost. This overview deals with the role of complement in the incompatibility reactions that occur when biomaterials come in contact with blood and other body fluids.
Similar articles
-
Biocompatibility: complement as mediator of tissue damage and as indicator of incompatibility.Exp Clin Immunogenet. 1997;14(1):24-9. Exp Clin Immunogenet. 1997. PMID: 9187920 Review.
-
Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes.Biomaterials. 2004 Nov;25(26):5681-703. doi: 10.1016/j.biomaterials.2004.01.023. Biomaterials. 2004. PMID: 15147815 Review.
-
Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.Clin Exp Immunol. 1991 Oct;86 Suppl 1(Suppl 1):21-6. Clin Exp Immunol. 1991. PMID: 1934602 Free PMC article.
-
[Inflammatory response and haematological disorders in cardiac surgery: toward a more physiological cardiopulmonary bypass].Ann Fr Anesth Reanim. 2006 May;25(5):510-20. doi: 10.1016/j.annfar.2005.12.002. Epub 2006 Feb 20. Ann Fr Anesth Reanim. 2006. PMID: 16488106 Review. French.
-
A review of the concept of biocompatibility.Kidney Int Suppl. 1993 Jun;41:S209-12. Kidney Int Suppl. 1993. PMID: 8320923 Review.
Cited by
-
Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantation.FASEB J. 2013 Jul;27(7):2768-76. doi: 10.1096/fj.12-225888. Epub 2013 Apr 4. FASEB J. 2013. PMID: 23558338 Free PMC article.
-
Innate Immunity and Biomaterials at the Nexus: Friends or Foes.Biomed Res Int. 2015;2015:342304. doi: 10.1155/2015/342304. Epub 2015 Jul 12. Biomed Res Int. 2015. PMID: 26247017 Free PMC article. Review.
-
Low concentrations of citrate reduce complement and granulocyte activation in vitro in human blood.Clin Kidney J. 2015 Feb;8(1):31-7. doi: 10.1093/ckj/sfu127. Epub 2014 Dec 1. Clin Kidney J. 2015. PMID: 25713707 Free PMC article.
-
Role of the Complement System in the Response to Orthopedic Biomaterials.Int J Mol Sci. 2018 Oct 27;19(11):3367. doi: 10.3390/ijms19113367. Int J Mol Sci. 2018. PMID: 30373272 Free PMC article. Review.
-
Predicting the In Vivo Performance of Cardiovascular Biomaterials: Current Approaches In Vitro Evaluation of Blood-Biomaterial Interactions.Int J Mol Sci. 2021 Oct 21;22(21):11390. doi: 10.3390/ijms222111390. Int J Mol Sci. 2021. PMID: 34768821 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
